Welcome to the latest edition of DNA Dispatch, the quarterly newsletter from OGT, your hybridization experts.
It has been a busy summer of conferences in Europe, during which OGT solutions were featured in impactful studies from leading experts and our own colleagues.
→ Measurable residual disease (MRD) analysis in a retrospective study of AML samples, by Sean Glenn, PhD (Roswell Park Comprehensive Cancer Center)
→ The use of error-corrected sequencing to investigate MRD status and identify AML relapse risk following transplantation, by Phillip Galbo, PhD (Roswell Park Comprehensive Cancer Center)
→ The development of an automated universal next-generation sequencing (NGS) workflow, by Sandra Kacchia (OGT)
By designing targeted solutions — like the MLL/MLLT3 Breakapart/Dual Fusion probe we developed for Leeds Teaching Hospitals NHS Trust — our myProbes® custom FISH probe service helps labs consolidate workflows and meet turnaround times with confidence.
"With the introduction of the MLL/MLLT3 Breakapart/Dual Fusion probe we were able to consolidate (two) probes into the use of a single probe, thereby enabling us to save practical and analytical time." Amy Foster, Leeds Teaching Hospitals NHS Trust
Watch a step-by-step workflow video from our NGS specialists on the pre-capture PCR of the ligated library and its following purification.
For the latest in our series of FISH and NGS quizzes we've set you the challenge of interpreting different FISH chromosome maps and correctly filling in the blanks of the probe description.
Put your FISH skills to the test and find out if you can score 100%.
In June we celebrated the 88th birthday of our founder, Sir Edwin Southern.
Revolutionizing molecular biology with the development of the Southern blot, Sir Edwin chose to make this technique freely accessible to the global scientific community, accelerating its growth across the field.
Later, Sir Edwin pioneered the microarray technology. This advancement led to his founding of our company, OGT, where microarrays remain central to our genomics portfolio.
Today, OGT continues to build on his legacy through integrated genomic solutions spanning microarrays, FISH and NGS, supporting laboratories worldwide.
We are proud to be part of a remarkable legacy that continues to shape molecular biology and genomics.
Don’t forget…Our FAS team can be contacted online with free support advice
Visit International site
Visit USA site
